THE EFFECTIVENESS OF CANNABINOIDS IN THE MANAGEMENT OF CHRONIC NONMALIGNANT NEUROPATHIC PAIN: A SYSTEMATIC REVIEW.
Darrell G. Boychuk, Greg Goddard, Giovanni Mauro, Maria F. Orellana
Journal Of Oral & Facial Pain and Headache 2015; 29:7 – 14. DOI: 10.11607/OFPH.1274
Systematic review of 13 studies shows that cannabis-based medicinal extracts may provide effective pain relief to patients suffering with chronic nonmalignant neuropathic pain, especially with conditions that are resistant to other treatments. However, there is a need for further high-quality studies to assess the impact of the duration of the treatment as well as the best form of drug delivery.
Pre-clinical studies documenting the anti-cancer effects of THC and its success in inhibiting cancer growth and spread have been on the rise. Clinical studies however are scarce as the psychoactive effects of THC can limit its medicinal and clinical use. Could non-psychoactive cannabinoids found in cannabis and hemp be the answer to treating cancer instead?
At ANTG, we are uniquely well-positioned to supply the domestic market and become the first medicinal cannabis company in Australia to export cannabis flower for commercial purposes to the EU. Interested in investing in medicinal cannabis? Read what sets ANTG apart.